XIFAXAN® (rifaximin) For Adults with Overt HE and IBS-D XIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults
Safety Profile and Dosing for IBS-D | XIFAXAN® (rifaximin) XIFAXAN ® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults
About Xifaxan for Adults with OHE | XIFAXAN® (rifaximin) XIFAXAN is the only FDA-approved medicine that reduces the risk of overt HE (hepatic encephalopathy) recurrence in adults In addition, it helps reduce the risk of HE-related hospitalizations